Brief: Processa Pharmaceuticals Terminates Licensing Agreement With Ocuphire Pharma - SEC Filing

Processa Pharmaceuticals

01/07/2025 14:15

July 1 (Reuters) - Processa Pharmaceuticals Inc PCSA.O:

PROCESSA PHARMACEUTICALS INC - TERMINATES LICENSING AGREEMENT WITH OCUPHIRE PHARMA - SEC FILING

PROCESSA PHARMACEUTICALS INC - ANNOUNCES STRATEGIC PORTFOLIO REVIEW AND PIPELINE REALIGNMENT

PROCESSA PHARMACEUTICALS INC - GRANTS INTACT THERAPEUTICS EXCLUSIVE OPTION TO LICENSE PCS12852

Source text: [ID:n0001641172-25-017288]

Further company coverage: PCSA.O

 ((Reuters.Briefs@thomsonreuters.com;))